JPS624269A - (+)-latifine and production thereof - Google Patents

(+)-latifine and production thereof

Info

Publication number
JPS624269A
JPS624269A JP14228785A JP14228785A JPS624269A JP S624269 A JPS624269 A JP S624269A JP 14228785 A JP14228785 A JP 14228785A JP 14228785 A JP14228785 A JP 14228785A JP S624269 A JPS624269 A JP S624269A
Authority
JP
Japan
Prior art keywords
latifine
solvent
benzyloxy
mmol
ether
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP14228785A
Other languages
Japanese (ja)
Other versions
JPH06755B2 (en
Inventor
Seiichi Takano
誠一 高野
Kuniro Ogasawara
国郎 小笠原
Masaji Akiyama
秋山 正司
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kawaken Fine Chemicals Co Ltd
Original Assignee
Kawaken Fine Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kawaken Fine Chemicals Co Ltd filed Critical Kawaken Fine Chemicals Co Ltd
Priority to JP14228785A priority Critical patent/JPH06755B2/en
Publication of JPS624269A publication Critical patent/JPS624269A/en
Publication of JPH06755B2 publication Critical patent/JPH06755B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

NEW MATERIAL:Optically active (+)-latifine expressed by formula I. USE:A medicine which is an optical isomer of (-)-latifine known as a rubefacient or tonic and a nonnatural alkaloid. PREPARATION:(R)-Dibenzyllatifine, expressed by formula III and synthesized from (R)-(E)-benzyloxy-4-(4-benzyloxyphenyl)-3-buten-2-ol, expressed by formula III and obtained from D-mannitol as a starting material is catalytically reduced with hydrogen to afford the aimed (+)-latifine.

Description

【発明の詳細な説明】 の1 本発明は、新規なアルカロイド (+)−ラテイフィン
およびその製造方法に関するものである。
DETAILED DESCRIPTION OF THE INVENTION Part 1: The present invention relates to a novel alkaloid (+)-lateifin and a method for producing the same.

【東へ11 (−)−ラティフィンは最近になってインドハマユウ(
Crinum Latifolium L、 )の葉よ
り抽出法によって発見された新しいアルカロイドである
[To the East 11 (-) - Latifin has recently become a common species of Indocanus (
This is a new alkaloid discovered by extraction from the leaves of Crinum Latifolium L.).

(小林、 J、Chem、Soc、Chem、Comm
un、、比社、1043 )インドハマユウの球根およ
び葉はインド、スリランカ地方の民間薬として使われて
おり、発赤剤や強壮剤としての効果が知られている。本
発明者等が研究した(+)−ラティフィンはその光学異
性体であり、非天然型の新規なアルカロイドである。
(Kobayashi, J, Chem, Soc, Chem, Comm
un,, Hisha, 1043) The bulbs and leaves of the Indian sycamore are used as folk medicine in India and Sri Lanka, and are known for their redness and tonic effects. The (+)-latifine studied by the present inventors is an optical isomer thereof, and is a novel non-natural alkaloid.

医薬分野における今後の発展が期待されている。Future developments in the pharmaceutical field are expected.

11へ1」 本発明は、新規なアルカロイド (+)−ラティフィン
およびその製造方法を提供するものである。
11 to 1'' The present invention provides a novel alkaloid (+)-latifine and a method for producing the same.

11へ1え 本発明は、式(T) で示される光学活性(+)−ラティフインおよび式(I
I) (式中、Bnはベンジル基を表す)で示される光学活性
(R)−ジベンジルラテイフィンを接触水素還元するこ
とからなる上記式(I)で示される光学活性(+)−ラ
ティフィンの製造方法である。
To 11 The present invention provides optically active (+)-latifine represented by the formula (T) and the formula (I
I) (wherein Bn represents a benzyl group) optically active (+)-latifine represented by the above formula (I), which is obtained by catalytic hydrogen reduction of optically active (R)-dibenzyl latefin represented by (Bn represents a benzyl group) This is the manufacturing method.

(+)−ラティフィンは無色結晶性の固体で、天然から
採取された(−)−ラティフィンと融点、NMR,MA
SS各スペクトルデータにおいて完全に一致し、旋光度
測定においてのみ異なるデータを与えた。
(+)-Latifine is a colorless crystalline solid, which has melting point, NMR, and MA compared to (-)-Latifin collected from nature.
SS gave complete agreement in each spectral data and different data only in the optical rotation measurement.

本発明の(+)−ラティフィンの製造方法の最終工程は
、(R)−ジベンジルラティフィンのベンジル基を接触
還元法によって脱離することによって完成される。接触
還元法において使用される触媒は通常の水素化反応用の
触媒であればいずれでも使用可能であるが、なかでもパ
ラジウム炭素触媒が最も好適なものである。使用される
溶媒としては反応に不活性なものであれば特に限定され
ないが、アルコール溶媒が最も望ましいものである。
The final step of the method for producing (+)-latifine of the present invention is completed by removing the benzyl group from (R)-dibenzyllatifine by a catalytic reduction method. The catalyst used in the catalytic reduction method may be any conventional catalyst for hydrogenation reactions, but palladium on carbon catalyst is the most preferred. The solvent used is not particularly limited as long as it is inert to the reaction, but alcohol solvents are most desirable.

反応は水素存在下、常圧ないし加圧条件下、反応温度常
温ないし100℃で遂行できる。反応生成物は触媒濾別
後通常の精製方法、例えば再結晶、再沈殿、カラムクロ
マトグラフィーなどを用いて精製し、高純度の(+)−
ラティフィンを得ることができる。
The reaction can be carried out in the presence of hydrogen, under normal pressure to pressurized conditions, and at a reaction temperature of room temperature to 100°C. After catalyst filtration, the reaction product is purified using conventional purification methods such as recrystallization, reprecipitation, column chromatography, etc. to obtain highly pure (+)-
You can get Latiffin.

本発明の製造方法の1例を吹口に示し、詳細は参考例お
よび実施例において説明する。
An example of the manufacturing method of the present invention is shown in the mouthpiece, and details will be explained in Reference Examples and Examples.

釡」」外−1(S)−(E)−4−ベンジルオキシ−1
−(4−ベンジルオキシフェニル)−3−(2−メトキ
シフェニルオキシ)−1−ブテン(b)の合成出発化合
物である (R>−(E)−1−ベンジルオキシ−4−
(4−ベンジルオキシフェニル)−3−ブテン−2−オ
ール(a)は、同日に出願した明m書に示されるように
D−マンニトールより製造された。この光学活性アリル
アルコール化合物1.67 g (4、64+u+ol
)とトリフェニルホスフィン1.83g (6,96m
mol)をTHF701に溶かし、それにグアイアコー
ル0.77m1(6,96mmol )とジイソプロピ
ルアゾジカルボキシレート1.37m1(6,96mm
ol)を0℃で攪拌しながら加えた。2時間反応後溶媒
を減圧下に除去し残渣を15%苛性ソーダ水溶液20m
1、水201飽和食塩水201で次々と洗浄し、最後に
無水硫酸マグネシュウムで乾燥後溶媒を除去した。残渣
はシリカゲル75gを用い、n−ヘキサン−酢酸エチル
(10:1)混合溶媒を展開剤としてクロマト精製し、
無色油状の表題のエーテル化合物1.04g(収率48
%)を得た。
Kama”” Soto-1(S)-(E)-4-benzyloxy-1
The starting compound for the synthesis of -(4-benzyloxyphenyl)-3-(2-methoxyphenyloxy)-1-butene (b) (R>-(E)-1-benzyloxy-4-
(4-Benzyloxyphenyl)-3-buten-2-ol (a) was prepared from D-mannitol as shown in the memo filed on the same day. This optically active allyl alcohol compound 1.67 g (4,64+u+ol
) and triphenylphosphine 1.83g (6,96m
Dissolve 0.77 ml (6.96 mmol) of guaiacol and 1.37 ml (6.96 mmol) of diisopropyl azodicarboxylate in THF701.
ol) was added with stirring at 0°C. After 2 hours of reaction, the solvent was removed under reduced pressure and the residue was dissolved in 20ml of 15% caustic soda aqueous solution.
1. Washed with 201 parts of water and 20 parts of saturated saline solution, and finally dried with anhydrous magnesium sulfate, and the solvent was removed. The residue was purified by chromatography using 75 g of silica gel and a mixed solvent of n-hexane-ethyl acetate (10:1) as a developing agent.
1.04 g of the title ether compound as a colorless oil (yield: 48
%) was obtained.

[α ]o    :  +13.87  °   (
C:2.264.CI(Ch)NMRδ: 3.7?(
2H,d、J=6.0Hz、−CI−CL−)、3.8
4(3H,s、−0CH3)、4.64(2H,s、−
CH2O−CH2−Ph)、4.96(IH,m、−C
)1−C)1z−)、5.02(20,s、Ar0CH
2−Ph)、6.11<IH,dd、J=16.0an
d6.0Hz、−C)l=c)I−CI)、6.58(
IH,d、 16.0Hz、−CH=CH−CH−)、
6.72−7.02(8H,m、ArH)、7.04−
7.48(IOH,m、 Phil)Ppm−2(R)
−(E)−4−ベンジルオキシ−1−(4−ベンジルオ
キシフェニル)−1−(2−ヒドロキシ−3−メトキシ
フェニル)−2−ブテン(e)の合成 参考例1で得たエーテル化合物1.04g(2,22m
mol)をN、N−ジメチルアニリン8mlに溶解し、
20分間還流する。反応液冷却後エーテル50m1を加
えて希釈し、それを10%塩酸水201で3回、飽和重
曹水20m1、飽和食塩水201で洗浄し、最後に無水
硫酸マグネシュウムで脱水し、減圧下に溶媒を除去した
。残渣をシリカゲル40gとn−ヘキサン−エーテル(
5:1)展開溶媒を使ってクロマト精製し、無色油状の
表題のフェノール化合物782 mg (収率76%)
を得た。
[α]o: +13.87° (
C:2.264. CI(Ch)NMRδ: 3.7? (
2H, d, J=6.0Hz, -CI-CL-), 3.8
4 (3H, s, -0CH3), 4.64 (2H, s, -
CH2O-CH2-Ph), 4.96 (IH, m, -C
)1-C)1z-), 5.02(20,s, Ar0CH
2-Ph), 6.11<IH, dd, J=16.0an
d6.0Hz, -C)l=c)I-CI), 6.58(
IH, d, 16.0Hz, -CH=CH-CH-),
6.72-7.02 (8H, m, ArH), 7.04-
7.48 (IOH, m, Phil) Ppm-2(R)
Synthesis of -(E)-4-benzyloxy-1-(4-benzyloxyphenyl)-1-(2-hydroxy-3-methoxyphenyl)-2-butene (e) Ether compound 1 obtained in Reference Example 1 .04g (2,22m
mol) in 8 ml of N,N-dimethylaniline,
Reflux for 20 minutes. After cooling the reaction solution, it was diluted with 50 ml of ether, washed three times with 20 ml of 10% hydrochloric acid solution, 20 ml of saturated sodium bicarbonate solution, and 20 ml of saturated brine, and finally dehydrated with anhydrous magnesium sulfate, and the solvent was removed under reduced pressure. Removed. The residue was mixed with 40 g of silica gel and n-hexane-ether (
5:1) Chromatographic purification using a developing solvent yielded 782 mg (yield 76%) of the title phenol compound as a colorless oil.
I got it.

[α] o  :  +5.11@(C=1.88. 
CHCl5)I RvlmaX  : 3350cm−
’NMRδ : 3.73(3H,s、−0CR3)、
4.02(2H,d、=CH−CH2−0)、4.44
(2t(、s、−CH2−Q−CH2−Phン、4.9
4(2H,5Ar−0−CH2−Ph)、5.03(I
H,m、−CH−CH=CH−)、5.67(IH,m
、−CHz)、5.73(IH,br、s、−0H)、
6.19(IH,m。
[α] o: +5.11@(C=1.88.
CHCl5)I RvlmaX: 3350cm-
'NMRδ: 3.73 (3H, s, -0CR3),
4.02 (2H, d, =CH-CH2-0), 4.44
(2t(, s, -CH2-Q-CH2-Phn, 4.9
4(2H,5Ar-0-CH2-Ph), 5.03(I
H, m, -CH-CH=CH-), 5.67 (IH, m
, -CHz), 5.73 (IH, br, s, -0H),
6.19 (IH, m.

=CH−1,6,58−7,52(17H,m、ArH
andPbH)ppmM A S S  m/z :4
66.2134(計算値 466.2142)元素分析
:実測値 C7g、59. )l 6.40計算値 C
78,29,H6,57 11九−L  (R)−(E )−4−ベンジルオキシ
−1−(4−ベンジルオキシフェニル)−1−(2−ベ
ンジルオキシ−3−メトキシフェニル)−2−ブテン(
d)の合成 参考例2で得たフェノール化合物782mg(1,68
m+aol)と臭化ベンジル0.30i1(2,521
1101)それに炭酸カリウム929@g(1,68m
mo1)をDMF15mlに加え、80℃で15時間反
応させた。反応液に水15m1を加えた後、エーテル3
01で2回抽出操作した。抽出エーテル液を水201、
飽和食塩水201で処理した後、無水硫酸マグネシュウ
ムで脱水し、減圧下に溶媒を除去した。残渣をシリカゲ
ル35gとn−ヘキサン−酢酸エチル(15:1)混合
溶媒を使用したカラム精製をし、表題のエーテル化合物
829 mg(収率89%)を無色シロップ状物として
得た。
=CH-1,6,58-7,52(17H,m,ArH
andPbH) ppmM A S S m/z: 4
66.2134 (calculated value 466.2142) Elemental analysis: Actual value C7g, 59. )l 6.40 Calculated value C
78,29,H6,57 119-L (R)-(E)-4-benzyloxy-1-(4-benzyloxyphenyl)-1-(2-benzyloxy-3-methoxyphenyl)-2- Butene (
Synthesis of d) 782 mg (1,68 mg) of the phenol compound obtained in Reference Example 2
m+aol) and benzyl bromide 0.30i1 (2,521
1101) and potassium carbonate 929@g (1,68m
mo1) was added to 15 ml of DMF and reacted at 80°C for 15 hours. After adding 15 ml of water to the reaction solution, 3 ml of ether
Extraction operation was performed twice with 01. The extracted ether solution was mixed with water 201,
After treatment with saturated brine 201, it was dehydrated with anhydrous magnesium sulfate, and the solvent was removed under reduced pressure. The residue was purified by a column using 35 g of silica gel and a mixed solvent of n-hexane-ethyl acetate (15:1) to obtain 829 mg (yield: 89%) of the title ether compound as a colorless syrup.

[α]o  :  +15.95°(C=1.868.
ClCl5)I Rv mix : 3050 、16
15cm−’NMRδ: 3.84(3H,s、−0C
L3)、3.99(2H,d、J”6.011z 、 
、 =CH−CL2−0) 、 4 、55(2H、s
 、’−CH2−O−CHz−Ph )。
[α]o: +15.95° (C=1.868.
ClCl5)I Rv mix: 3050, 16
15cm-'NMRδ: 3.84 (3H,s, -0C
L3), 3.99 (2H, d, J"6.011z,
, =CH-CL2-0) , 4, 55(2H, s
,'-CH2-O-CHz-Ph).

4.66と4.90(各IH,d、J11.OHz  
、/−0−C)+2−Ph)4.98(2H,s、 A
r−0−CH2−Ph)、5.14(IH,d、J=6
.8Hz、−CI−CH: )、5.64(IH,dt
、J=15.7and6.0Hz、−CH=CH−CH
2−)、6.07(IH,dd、J=15.7and6
.8Hz、−CH−CI=Cfl−)、6.64−7.
14(7H,m、入rH)、7.08−7.44(15
n、m、phH)ppm M A S S  m/z :556.2604(計算
値 556.2612)元素分析:実測値 C81,7
7、H6,62計算値 C81,9g、 H6,52 4(R)−2−(4−ベンジルオキシフェニル)−2−
(2−ベンジルオキシ−3−メトキシフェニル)エチル
アルコール(e)の合成参考例3で得たエーテル化合物
829mg(1゜49mmol)をメタノール30m1
と塩化メチル101の混合溶媒に溶解し、それに−74
℃で35分間オゾンガスを吹込む。次に窒素ガスを吹込
んで過剰のオゾンを追い出した後、低温のままソジウム
ボロハイドライド564mg(14,9m+++ol)
の水溶液を加え、その後しだいに室温まで加温する。
4.66 and 4.90 (each IH, d, J11.OHz
, /-0-C)+2-Ph)4.98(2H,s, A
r-0-CH2-Ph), 5.14 (IH, d, J=6
.. 8Hz, -CI-CH: ), 5.64(IH, dt
, J=15.7and6.0Hz, -CH=CH-CH
2-), 6.07 (IH, dd, J=15.7and6
.. 8Hz, -CH-CI=Cfl-), 6.64-7.
14 (7H, m, input rH), 7.08-7.44 (15
n, m, phH) ppm MA S S m/z: 556.2604 (calculated value 556.2612) Elemental analysis: Actual value C81,7
7, H6,62 calculated value C81,9g, H6,52 4(R)-2-(4-benzyloxyphenyl)-2-
Synthesis of (2-benzyloxy-3-methoxyphenyl)ethyl alcohol (e) 829 mg (1°49 mmol) of the ether compound obtained in Reference Example 3 was mixed with 30 ml of methanol.
and methyl chloride 101, and -74
Bubble ozone gas for 35 minutes at ℃. Next, after blowing in nitrogen gas to drive out excess ozone, 564mg (14.9m+++ol) of sodium borohydride was added at a low temperature.
Add an aqueous solution of and then gradually warm to room temperature.

反応液は減圧下に溶媒を除去し残渣をエーテル50m1
で抽出する。抽出液は水201、飽和食塩水201で洗
浄処理後、無水硫酸マグネシュウムで脱水され、減圧下
に溶媒を除去する。残渣はシリカゲル25gとn−ヘキ
サン−エーテル(1:1)混合溶媒を使用したカラム精
製を行い表題のアルコール化合物422mg(収率64
%)を得た。
The solvent of the reaction solution was removed under reduced pressure, and the residue was dissolved in 50 ml of ether.
Extract with The extract is washed with water 201 and saturated saline 201, then dehydrated with anhydrous magnesium sulfate, and the solvent is removed under reduced pressure. The residue was purified by column using 25 g of silica gel and n-hexane-ether (1:1) mixed solvent to obtain 422 mg of the title alcohol compound (yield 64
%) was obtained.

[α]o  :  +34.48°(C=1.978.
CHCl3)IRν畷ロ :  3450cm−’ NMRδ: 1.53(IH,s、−0H)、3.86
(3H,s、−0CH3)4.01(2H,d、Jニア
、0)1z、−CH2−0H)、4.56(Ill、t
、J=7、OH2,−CH−CH2−)、4.71と4
.99(各IH,d、J=11.0Hz、−CH2−P
h)、6.70−7.50(7H,m、ArH)、7.
33(IOH,s、PhH)ppm M A S S  m/z:440.1998 (計算
値 440.1988)釡][倒ニー5   (R)−
1−フタルイミド−2−(4−ベンジルオキシフェニル
)−2−(2−ベンジルオキシ−3−メトキシフェニル
)エタン(f)の合成参考例4の生成物422+ag(
0,959mmol)フタルイミド212+ag(1、
446mmol)およびトリフェニルホスフィン326
B(1,247mmof)をテトラヒドロフラン121
に溶解し、水冷下ジエチルアゾジカルボキシレート0.
26m1(1、63:12++i+ol)を滴下した。
[α]o: +34.48° (C=1.978.
CHCl3) IR ν: 3450 cm-' NMR δ: 1.53 (IH, s, -0H), 3.86
(3H, s, -0CH3) 4.01 (2H, d, J near, 0) 1z, -CH2-0H), 4.56 (Ill, t
, J=7, OH2, -CH-CH2-), 4.71 and 4
.. 99 (each IH, d, J = 11.0Hz, -CH2-P
h), 6.70-7.50 (7H, m, ArH), 7.
33 (IOH, s, PhH) ppm M A S S m/z: 440.1998 (calculated value 440.1988) pot] [down knee 5 (R)-
Synthesis of 1-phthalimido-2-(4-benzyloxyphenyl)-2-(2-benzyloxy-3-methoxyphenyl)ethane (f) Product 422+ag(
0,959 mmol) Phthalimide 212+ag (1,
446 mmol) and triphenylphosphine 326
B (1,247 mmof) in tetrahydrofuran 121
Dissolve diethyl azodicarboxylate in 0.0% and cool with water.
26 ml (1,63:12++i+ol) was added dropwise.

後の操作は委考例4とほぼ同様に行い、無色半固体状の
表題化合物519mg(収率95%)を得た。
The subsequent operations were carried out in substantially the same manner as in Reference Example 4 to obtain 519 mg (yield 95%) of the title compound in the form of a colorless semi-solid.

[α コ D    :   +14j5  ° (C
=1.714.CHCl、)NMRδ: 3.66(3
1(、s>、4.18(2H,d、J=Il)lz)、
4.65と4.93(IH,d、J=lIHz)、5.
17(IH,t、J=8Hz)、6.53−7.86(
IIH,m)、 7.24(IOH,s)ppm11燵
−6(R)−2−(4−ベンジルオキシフェニル)−2
−(2−ベンジルオキシ−3−メトキシフェニル)−1
−エチルアミン(g)の合成参考例5の生成物519m
g(0,912m+ool)をエタノール101に溶解
し、90%ヒドラジン1水和物159mg(2,743
mmol)を加え、2時間加熱還流した。冷却後溶媒を
留去し、残渣にクロロホルムを加え、不溶物を濾過した
。溶媒を除くと無色油状物が得られ、これをシリカゲル
カラムクロマトグラフィーによって精製し、表題化合物
374mg(収率93%)を得た。
[α Ko D: +14j5 ° (C
=1.714. CHCl, )NMRδ: 3.66 (3
1(,s>,4.18(2H,d,J=Il)lz),
4.65 and 4.93 (IH, d, J=lIHz), 5.
17 (IH, t, J=8Hz), 6.53-7.86 (
IIH, m), 7.24 (IOH, s) ppm 11 Katsu-6(R)-2-(4-benzyloxyphenyl)-2
-(2-benzyloxy-3-methoxyphenyl)-1
- Synthesis of ethylamine (g) Product 519m of Reference Example 5
g (0,912 m + ool) was dissolved in ethanol 101, and 159 mg (2,743
mmol) and heated under reflux for 2 hours. After cooling, the solvent was distilled off, chloroform was added to the residue, and insoluble matter was filtered. Removal of the solvent gave a colorless oil, which was purified by silica gel column chromatography to obtain 374 mg (yield 93%) of the title compound.

[α コ o     :   +29.76  ° 
 (C=1.942.CHCl 3)NMRδ: 1.
54(2H,s)、3.12(2H,d、J=8Hz)
、3.82(3H,s)、4j3(IH,t、J=8H
z>、4.68と4.99(1B、d。
[α co: +29.76 °
(C=1.942.CHCl3) NMRδ: 1.
54 (2H, s), 3.12 (2H, d, J=8Hz)
, 3.82 (3H, s), 4j3 (IH, t, J=8H
z>, 4.68 and 4.99 (1B, d.

JllHz>、6.65−7.45(7H,m)、7.
30(10H,s)ppm11九−7(R)−N−ホル
ミル−2−(4−ベンジルオキシフェニル)−2−(2
−ベンジルオキシ−3−メトキシフェニル)−1−エチ
ルアミン (h)の合成 参考例6の生成物312mg(0,711mmol)を
ピリジン51に溶解し、水冷上酢酸蟻酸混合無水物0 
、13ml’(2、83mmol)を滴下した。同温度
で45分間攪拌後、減圧下ピリジンを留去し残渣をエー
テルに溶解した。その後の操作は参考例4に準じて精製
処理を行い、無色ガラス状の表題化合物297+++g
(収率89%)を得た。
JllHz>, 6.65-7.45 (7H, m), 7.
30(10H,s)ppm119-7(R)-N-formyl-2-(4-benzyloxyphenyl)-2-(2
Synthesis of -benzyloxy-3-methoxyphenyl)-1-ethylamine (h) 312 mg (0,711 mmol) of the product of Reference Example 6 was dissolved in pyridine 51, and acetic acid formic acid mixed anhydride was added to the solution after cooling with water.
, 13 ml' (2,83 mmol) was added dropwise. After stirring at the same temperature for 45 minutes, pyridine was distilled off under reduced pressure and the residue was dissolved in ether. After that, purification was carried out according to Reference Example 4, and 297 +++ g of the title compound was obtained as a colorless glass.
(yield 89%).

[α] o  :  +25.31 ’ (C・2.2
84.CHCl、)NMRδ: 3.36(2H,m)
、3.81(31,s)、4.47(It(、d。
[α] o: +25.31' (C・2.2
84. CHCl, )NMRδ: 3.36 (2H, m)
, 3.81(31,s), 4.47(It(,d.

J・9)1z)、4.71と4.99(IH,d、J=
11Hz)、4.95(2H。
J・9) 1z), 4.71 and 4.99 (IH, d, J=
11Hz), 4.95 (2H.

s)、5.53(IH,s)、6.53−7.50(7
H,a)、7.29(,10H,s)、 7.96(I
H,d)ppm 釡」L侶ニー8   (R)−N−メチル−2−(4−
ベンジルオキシフェニル)−2−(2−ベンジルオキシ
−3−メトキシフェニル)−1−エチルアミン(+)の
合成 参考例7の生成物297mg(0,636mmol)を
テトラヒドロフラン71に溶解し、水冷下アンモニア水
21を注意深く滴下し、エーテル301で希釈した後セ
ライト0.7gを加えた。無水硫酸マグネシュウム層に
とうしながら吸引濾過し、溶媒を留去すると無色油状の
表題化合物217mg(収率75%)が得られた。
s), 5.53 (IH, s), 6.53-7.50 (7
H,a), 7.29(,10H,s), 7.96(I
H, d) ppm 8 (R)-N-methyl-2-(4-
Synthesis of benzyloxyphenyl)-2-(2-benzyloxy-3-methoxyphenyl)-1-ethylamine (+) 297 mg (0,636 mmol) of the product of Reference Example 7 was dissolved in tetrahydrofuran 71, and dissolved in aqueous ammonia under water cooling. 21 was carefully added dropwise, and after diluting with ether 301, 0.7 g of Celite was added. The mixture was filtered with suction while passing through an anhydrous magnesium sulfate layer, and the solvent was distilled off to obtain 217 mg (yield: 75%) of the title compound as a colorless oil.

[α コ 。    :   +28.76  °  
(C=1.794.ClCl、)NMRδ: 1.93
(IH,s)、2j5(3H,s)、3.08(2H,
d。
[α ko. : +28.76°
(C=1.794.ClCl,)NMRδ: 1.93
(IH, s), 2j5 (3H, s), 3.08 (2H,
d.

JJHz)、3.81(3H,s)、4.60(IH,
t、J=8Hz>、4.69と4.9g(1)[、d、
J・l1flz)、 6.63−7.56(7H,!+
)、 7.32(IOH,s)ppm 11九−% (R)−N−メチル−N−ホルミル−2−
く4−ベンジルオキシフェニル)−2−(2−ベンジル
オキシ−3−メトキシフェニル)−1−エチルアミン(
j>の合成 参考例8の生成物217mg(0、479mmol)を
ピリジン1.51に溶解し、水冷上酢酸蟻酸混合無水物
0.10m1(1,92mmol>を滴下した。
JJHz), 3.81 (3H, s), 4.60 (IH,
t, J=8Hz>,4.69 and 4.9g(1)[,d,
J・l1flz), 6.63-7.56 (7H,!+
), 7.32 (IOH, s) ppm 119-% (R)-N-methyl-N-formyl-2-
4-benzyloxyphenyl)-2-(2-benzyloxy-3-methoxyphenyl)-1-ethylamine (
Synthesis of 217 mg (0.479 mmol) of the product of Reference Example 8 was dissolved in 1.51 liters of pyridine, and 0.10 ml (1.92 mmol) of acetic formic acid mixed anhydride was added dropwise over water cooling.

40分間反応後減圧下ピリジンを留去し、残渣をエーテ
ルに溶解した。その後の操作は参考例4に準じて精製処
理を行い、無色ガラス状の表題化合物179a+g(収
率80%)を得た。
After reacting for 40 minutes, pyridine was distilled off under reduced pressure, and the residue was dissolved in ether. Thereafter, purification was carried out in accordance with Reference Example 4 to obtain colorless glassy title compound 179a+g (yield: 80%).

[(Z]D  :  +32.64°(C=0.772
.CIClCl5)N   δ: 2.60と2.66
(3H,s)、3.64(2H,d 、J=8[1z)
、3.82(3H,s>、4.53(IH,t、J=8
Hz)、4.70と4.96(IH,d、J=IIHz
)、4.96(2H,s)、6.63−7.50(7H
,m)7jl(IOH,s>、7.67と7.82(I
H,bs)ppm釡]LA−10(R)−ジベンジルラ
ティフィン(I[)の合成 参考例って得た生成物179mg(0,383mm01
)をベンゼン8,61に溶解し、オキシ塩化リン0.2
3+al(1,94ma+ol)を加え45分間加熱還
流した。減圧下ベンゼンを留去し、残渣をn−ヘキサン
10m1で3回洗浄した。それを10%合水メタノール
10m1に溶解し、水冷下ソジウムボロハイドライド1
43mg(3,83mmol)を加え、同温度で1時間
攪拌した。50”Cに加温して発泡が収まったら、減圧
上溶媒を留去し、残渣をエーテル60m1に溶解し、水
30m1、飽和食塩水30m1で洗浄した。無水硫酸マ
グネシュウムで乾燥後溶媒を留去し、これを分取薄層ク
ロマトグラフィーにより精製し、無色油状の表題化合物
132mg(収率76%)を得た。
[(Z]D: +32.64° (C=0.772
.. CIClCl5)N δ: 2.60 and 2.66
(3H,s), 3.64(2H,d, J=8[1z)
, 3.82(3H,s>, 4.53(IH,t, J=8
Hz), 4.70 and 4.96 (IH, d, J=IIHz
), 4.96 (2H, s), 6.63-7.50 (7H
, m) 7jl(IOH,s>, 7.67 and 7.82(I
179 mg (0,383 mm01
) in benzene 8,61, phosphorus oxychloride 0.2
3+al (1,94ma+ol) was added and heated under reflux for 45 minutes. Benzene was distilled off under reduced pressure, and the residue was washed three times with 10 ml of n-hexane. Dissolve it in 10 ml of 10% diluted methanol, and add 1 ml of sodium borohydride under water cooling.
43 mg (3.83 mmol) was added and stirred at the same temperature for 1 hour. After heating to 50"C and foaming subsided, the solvent was distilled off under reduced pressure. The residue was dissolved in 60 ml of ether, and washed with 30 ml of water and 30 ml of saturated brine. After drying over anhydrous magnesium sulfate, the solvent was distilled off. This was purified by preparative thin layer chromatography to obtain 132 mg (yield 76%) of the title compound as a colorless oil.

[α]。 :  + 4jl ’ (C・0.882.
CIClCl5)N  δ: 2.26(3H,s)、
2.68(2H,d、J=4Hz)j、30と3.85
<LH,d、J=14Hz)、3.80(3H,s)、
3.91と4゜80(IH,d、J=10Hz)、4.
23(IH,t、J=4Hz)、4.92(2H、s)
、6.60−7.45(7H,m)、7.21(IOH
,s)p’pm+M A S S  m/z:465.
2295 (計算値 465.2302)実[1(+)
−ラティフィンの合成 参考例10で得た (R)−ジベンジルラティフィン1
32mg(0,291mmol)をエタノール7mlに
溶解し10%バラジュウム炭素触媒36mgを加え、水
素気流中55°Cに加温して24時間攪拌した。セライ
ト層にとうしながら触媒を吸引濾過し。
[α]. : + 4jl' (C・0.882.
CIClCl5)N δ: 2.26 (3H, s),
2.68 (2H, d, J=4Hz)j, 30 and 3.85
<LH, d, J=14Hz), 3.80 (3H, s),
3.91 and 4°80 (IH, d, J = 10Hz), 4.
23 (IH, t, J=4Hz), 4.92 (2H, s)
, 6.60-7.45 (7H, m), 7.21 (IOH
, s) p'pm+M A S S m/z: 465.
2295 (calculated value 465.2302) real [1(+)
-(R)-Dibenzyllatifine 1 obtained in Synthesis of Latifin Reference Example 10
32 mg (0,291 mmol) was dissolved in 7 ml of ethanol, 36 mg of 10% baradium carbon catalyst was added, and the mixture was heated to 55°C in a hydrogen stream and stirred for 24 hours. Suction filter the catalyst while passing it through a Celite layer.

減圧下に溶媒を除去して黄褐色結晶を得た。これをエタ
ノール4mlより再結晶して黄色プリズム状の(+〉−
ラティフィン75mg(収率100%)を得た。
The solvent was removed under reduced pressure to obtain tan crystals. This was recrystallized from 4 ml of ethanol to give a yellow prism-like (+>-
75 mg (yield 100%) of Latifin was obtained.

融  点  :  213−217°C(分解)[α]
 o   :  + 9j9 ° (C=0.362.
CH30H)NMRδ: 2.31(3Ls)、2.6
3と2.89(IH,d、J=lOHz)、 3.43
と3.63(In、d、J=14Hz)、3.80(3
H,S)。
Melting point: 213-217°C (decomposition) [α]
o: +9j9° (C=0.362.
CH30H) NMRδ: 2.31 (3Ls), 2.6
3 and 2.89 (IH, d, J = lOHz), 3.43
and 3.63 (In, d, J = 14 Hz), 3.80 (3
H, S).

4.24(IH,t、、h5Hz>、6゜61と6.8
2(IH,d、J・9Hz)6.62と6.88(2H
,d、J=81(z)ppmIQ11 本発明によって新しい医薬成分(+)−ラティフィンの
有機合成手段による製造が可能になった。
4.24 (IH, t,, h5Hz>, 6°61 and 6.8
2 (IH, d, J・9Hz) 6.62 and 6.88 (2H
, d, J=81(z)ppmIQ11 The present invention has made it possible to produce a new pharmaceutical ingredient (+)-latifin by organic synthesis means.

また本発明の方法を応用して (−)−ラティフィンの
供給も可能である。
It is also possible to supply (-)-latifine by applying the method of the present invention.

Claims (2)

【特許請求の範囲】[Claims] (1)式( I ) ▲数式、化学式、表等があります▼( I ) で示される光学活性(+)−ラティフィン。(1) Formula (I) ▲There are mathematical formulas, chemical formulas, tables, etc.▼(I) Optically active (+)-latifin represented by. (2)式(II) ▲数式、化学式、表等があります▼(II) で示される(R)−ジベンジルラティフィンを接触水素
還元してなる(+)−ラティフィンの製造方法。
(2) Formula (II) ▲ Numerical formulas, chemical formulas, tables, etc. are available ▼ (II) A method for producing (+)-latifine, which is obtained by catalytic hydrogen reduction of (R)-dibenzyllatifine.
JP14228785A 1985-06-28 1985-06-28 (+)-Lattein and method for producing the same Expired - Lifetime JPH06755B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14228785A JPH06755B2 (en) 1985-06-28 1985-06-28 (+)-Lattein and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14228785A JPH06755B2 (en) 1985-06-28 1985-06-28 (+)-Lattein and method for producing the same

Publications (2)

Publication Number Publication Date
JPS624269A true JPS624269A (en) 1987-01-10
JPH06755B2 JPH06755B2 (en) 1994-01-05

Family

ID=15311863

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14228785A Expired - Lifetime JPH06755B2 (en) 1985-06-28 1985-06-28 (+)-Lattein and method for producing the same

Country Status (1)

Country Link
JP (1) JPH06755B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010215566A (en) * 2009-03-17 2010-09-30 Noevir Co Ltd Humectant, anti-aging agent, neutral fat accumulation inhibitor, bleaching agent, anti-inflammatory agent, skin agent for external use and oral agent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010215566A (en) * 2009-03-17 2010-09-30 Noevir Co Ltd Humectant, anti-aging agent, neutral fat accumulation inhibitor, bleaching agent, anti-inflammatory agent, skin agent for external use and oral agent

Also Published As

Publication number Publication date
JPH06755B2 (en) 1994-01-05

Similar Documents

Publication Publication Date Title
JP2001514666A (en) Synthesis of 2-alkoxyestradiol
NO328015B1 (en) The novel hydronaphthalene compound prepared by rhodium-catalyzed ring-opening reaction in the presence of phosphine ligand, as well as preparations comprising such compounds
JP2784202B2 (en) Process for producing 4-demethoxy-daunonomycinone, which is an aglycone of 4-demethoxy-daunorubicin
JPH0639468B2 (en) Hydroquinone derivative
CN108440384B (en) Process for the preparation of trifluoromethylated derivatives of isoindolones
JPS624269A (en) (+)-latifine and production thereof
JPS61129145A (en) Manufacture of hydroquinone derivative
CN110590722B (en) Synthesis method of 2-trifluoromethyl benzofuran derivative
RU2448957C2 (en) Fluorinated catharantine derivatives, their obtaining and application as precursors of dimeric vinca alkaloids
JPH0572387B2 (en)
CN113620789B (en) Chiral alpha-fluoroalkoxy alcohol and preparation method thereof
JP2857760B2 (en) Production method of propoxynitrobenzenes
JPH0570434A (en) Production of novel 2-hydroxymethyl-4-methoxy-3,5-dimethylpyridine and its intermediate and their production
JPS62198678A (en) Manufacture of fluorinated o-diaminobenzo-1,4-dioxenes
CN103476745A (en) Diamine compound containing sulfonic acid group, and method for producing same
CN113620789A (en) Chiral alpha-fluoroalkoxy alcohol and preparation method thereof
JP3432880B2 (en) Preparation of optically active azaspiro compounds
JPS63239238A (en) Manufacture of optically active carbonyl compound
JPH0314561A (en) Antibiotic cc-1065 fragment
JPH027583B2 (en)
JPS5846515B2 (en) Method for producing indole derivatives
JPS6136262A (en) Piperidino-propane or piperidino-propanol derivative and preparation thereof
JP3953225B2 (en) Method for producing quinoline derivative
JPH02732A (en) Propoxybenzene derivative and production thereof
JPH03176463A (en) Pyrrolidinol derivative and its production